<DOC>
	<DOC>NCT01268371</DOC>
	<brief_summary>To compare the safety and efficacy of coronary stenting with everolimus-eluting stent (Promus Element®) and biolimus-eluting stent with biodegradable polymer (Nobori®)</brief_summary>
	<brief_title>Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Significant coronary artery stenosis (&gt; 50% by visual estimate) Stable angina, unstable angina, NonST elevation myocardial infarction (NSTEMI) and documented silent ischemia Patients eligible for intracoronary stenting age ≥ 20 years old ST segment elevation myocardial infarction (within 24 hours) Low ejection fraction (&lt; 25%) Cardiogenic shock History of bleeding diathesis or known coagulopathy Limited lifeexpectancy (less than 1 year) due to combined serious disease Contraindication to heparin, sirolimus, everolimus and biolimus Contraindication to aspirin and clopidogrel Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Stent</keyword>
</DOC>